Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial von Parker, Christopher C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Hoyle, Alex P, Ali, Adnan, Ritchie, Alastair W S, Attard, Gerhardt, Chowdhury, Simon, Cross, William, Dearnaley, David P, Gillessen, Silke, Gilson, Clare, Jones, Robert J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Russell, J Martin, Thalmann, George N, Amos, Claire L, Alonzi, Roberto, Bahl, Amit, Birtle, Alison, Din, Omar, Douis, Hassan, Eswar, Chinnamani, Gale, Joanna, Gannon, Melissa R, Jonnada, Sai, Khaksar, Sara, Lester, Jason F, O'Sullivan, Joe M, Parikh, Omi A, Pedley, Ian D, Pudney, Delia M, Sheehan, Denise J, Srihari, Narayanan Nair, Tran, Anna T H, Parmar, Mahesh K B, Sydes, Matthew R

Volltext

Genomics of lethal prostate cancer at diagnosis and castration resistance von Mateo, Joaquin, Seed, George, Bertan, Claudia, Rescigno, Pasquale, Dolling, David, Figueiredo, Ines, Miranda, Susana, Nava Rodrigues, Daniel, Gurel, Bora, Clarke, Matthew, Atkin, Mark, Chandler, Rob, Messina, Carlo, Sumanasuriya, Semini, Bianchini, Diletta, Barrero, Maialen, Petermolo, Antonella, Zafeiriou, Zafeiris, Fontes, Mariane, Perez-Lopez, Raquel, Tunariu, Nina, Fulton, Ben, Jones, Robert, McGovern, Ursula, Ralph, Christy, Varughese, Mohini, Parikh, Omi, Jain, Suneil, Elliott, Tony, Sandhu, Shahneen, Porta, Nuria, Hall, Emma, Yuan, Wei, Carreira, Suzanne, de Bono, Johann S

Volltext

Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer (mCRPC): Results from an expanded access program von Thomson, David, Charnley, Natalie, Parikh, Omi

Volltext

Comparing Clinical Outcomes for Radium 223 – Do Older Patients Do Worse? von Song, Yee Pei, MB BCh., MRCP, Ellis, Tracey, BSc., MSc, Walshaw, Richard, MB ChB., MRCP., FRCR, Mbanu, Peter, MB ChB., MRCP, Parikh, Omi, BSc(Hons)., MB ChB(Hons)., MRCP., FRCR, Logue, John, MB ChB., MRCP., FRCR, Choudhury, Ananya, MA., PhD., MRCP., FRCR

Volltext

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registr... von Bjartell, Anders, Costa, Luis, Kramer, Gero, Zurawski, Bogdan, Galli, Luca, Werbrouck, Patrick, Ecke, Thorsten, Parikh, Omi, Bennamoun, Mostefa, Garcia Freire, Camilo, Peer, Avivit, Ljungberg, Börje, Cicin, Irfan, Smith, Emma, Lukac, Martin, Wapenaar, Robert, Chowdhury, Simon

Volltext

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma von Oudard, Stephane, Benhamouda, Nadine, Escudier, Bernard, Ravel, Patrice, Tran, Thi, Levionnois, Emeline, Negrier, Sylvie, Barthelemy, Philippe, Berdah, Jean François, Gross-Goupil, Marine, Sternberg, Cora N, Bono, Petri, Porta, Camillo, De Giorgi, Ugo, Parikh, Omi, Hawkins, Robert, Highley, Martin, Wilke, Jochen, Decker, Thomas, Tanchot, Corinne, Gey, Alain, Terme, Magali, Tartour, Eric

Volltext

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study von Lindskog, Magnus, Laurell, Anna, Kjellman, Anders, Melichar, Bohuslav, Rey, Pablo Maroto, Zieliński, Henryk, Villacampa, Felipe, Bigot, Pierre, Zoltan, Bajory, Parikh, Omi, Alba, David Vazquez, Jellvert, Åsa, Flaskó, Tibor, Gallardo, Enrique, Caparrós, Maria José Ribal, Purkalne, Gunta, Suenaert, Peter, Karlsson-Parra, Alex, Ljungberg, Börje

Volltext

Factors involved in treatment preference in patients with renal cancer: pazopanib versus sunitinib von Mitchell, Catherine C, Parikh, Omi A

Volltext

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial von Mateo, Joaquin, Porta, Nuria, Bianchini, Diletta, McGovern, Ursula, Elliott, Tony, Jones, Robert, Syndikus, Isabel, Ralph, Christy, Jain, Suneil, Varughese, Mohini, Parikh, Omi, Crabb, Simon, Robinson, Angus, McLaren, Duncan, Birtle, Alison, Tanguay, Jacob, Miranda, Susana, Figueiredo, Ines, Seed, George, Bertan, Claudia, Flohr, Penny, Ebbs, Berni, Rescigno, Pasquale, Fowler, Gemma, Ferreira, Ana, Riisnaes, Ruth, Pereira, Rita, Curcean, Andra, Chandler, Robert, Clarke, Matthew, Gurel, Bora, Crespo, Mateus, Nava Rodrigues, Daniel, Sandhu, Shahneen, Espinasse, Aude, Chatfield, Peter, Tunariu, Nina, Yuan, Wei, Hall, Emma, Carreira, Suzanne, de Bono, Johann S

Volltext

Genomics of lethal prostate cancer at diagnosis and castration resistance von Mateo, Joaquin, Seed, George, Bertan, Claudia, Rescigno, Pasquale, Dolling, David, Figueiredo, Ines, Miranda, Susana, Rodrigues, Daniel Nava, Gurel, Bora, Clarke, Matthew, Atkin, Mark, Chandler, Rob, Messina, Carlo, Sumanasuriya, Semini, Bianchini, Diletta, Barrero, Maialen, Petermolo, Antonella, Zafeiriou, Zafeiris, Fontes, Mariane, Perez-Lopez, Raquel, Tunariu, Nina, Fulton, Ben, Jones, Robert, McGovern, Ursula, Ralph, Christy, Varughese, Mohini, Parikh, Omi, Jain, Suneil, Elliott, Tony, Sandhu, Shahneen, Porta, Nuria, Hall, Emma, Yuan, Wei, Carreira, Suzanne, de Bono, Johann S.

Volltext

Severe Thrombocytopenia Induced by a Single Infusion of Trastuzumab von Parikh, Omi, Neave, Farhad, Palmieri, Carlo

Volltext

Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer von Thomson, David, Charnley, Natalie, Parikh, Omi

Volltext

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study von ESCUDIER, Bernard, PORTA, Camillo, SEVIN, Emmanuel, NEGRIER, Sylvie, KHAN, Sadya, DIAZ, Jose, REDHU, Suman, MEHMUD, Faisal, CELLA, David, BONO, Petri, POWLES, Thomas, EISEN, Tim, STERNBERG, Cora N, GSCHWEND, Jürgen E, DE GIORGI, Ugo, PARIKH, Omi, HAWKINS, Robert

Volltext

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy von James, Nicholas D, de Bono, Johann S, Spears, Melissa R, Clarke, Noel W, Mason, Malcolm D, Dearnaley, David P, Ritchie, Alastair W.S, Amos, Claire L, Gilson, Clare, Jones, Rob J, Matheson, David, Millman, Robin, Attard, Gerhardt, Chowdhury, Simon, Cross, William R, Gillessen, Silke, Parker, Christopher C, Russell, J. Martin, Berthold, Dominik R, Brawley, Chris, Adab, Fawzi, Aung, San, Birtle, Alison J, Bowen, Jo, Brock, Susannah, Chakraborti, Prabir, Ferguson, Catherine, Gale, Joanna, Gray, Emma, Hingorani, Mohan, Hoskin, Peter J, Lester, Jason F, Malik, Zafar I, McKinna, Fiona, McPhail, Neil, Money-Kyrle, Julian, O’Sullivan, Joe, Parikh, Omi, Protheroe, Andrew, Robinson, Angus, Srihari, Narayanan N, Thomas, Carys, Wagstaff, John, Wylie, James, Zarkar, Anjali, Parmar, Mahesh K.B, Sydes, Matthew R

Volltext

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial von Motzer, Robert J, Russo, Paul, Grünwald, Viktor, Tomita, Yoshihiko, Zurawski, Bogdan, Parikh, Omi, Buti, Sebastiano, Barthélémy, Philippe, Goh, Jeffrey C, Ye, Dingwei, Lingua, Alejo, Lattouf, Jean-Baptiste, Albigès, Laurence, George, Saby, Shuch, Brian, Sosman, Jeffrey, Staehler, Michael, Vázquez Estévez, Sergio, Simsek, Burcin, Spiridigliozzi, Julia, Chudnovsky, Aleksander, Bex, Axel

Volltext

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study von Siefker-Radtke, Arlene O, Necchi, Andrea, Park, Se Hoon, García-Donas, Jesús, Huddart, Robert A, Burgess, Earle F, Fleming, Mark T, Rezazadeh Kalebasty, Arash, Mellado, Begoña, Varlamov, Sergei, Joshi, Monika, Duran, Ignacio, Tagawa, Scott T, Zakharia, Yousef, Akapame, Sydney, Santiago-Walker, Ademi E, Monga, Manish, O'Hagan, Anne, Loriot, Yohann, Necchi, Andrea, Loriot, Yohann, Park, Se Hoon, Tagawa, Scott, Flechon, Aude, Alexeev, Boris, Varlamov, Sergey, Huddart, Robert, Vano, Yann, Gasparro, Donatello, Hamzaj, Alketa, Kopyltsov, Eugeniy, Gracia Donas, Jesus, Mellado, Begona, Parikh, Omi, Schatteman, Peter, Culine, Stephane, Houédé, Nadine, Zanetta, Sylvie, Facchini, Gaetano, Scagliotti, Giorgio, Schinzari, Giovanni, Lee, Jae Lyun, Shkolnik, Mikhail, Fleming, Mark, Joshi, Monica, O'Donnell, Peter, Stöger, Herbert, Decaestecker, Karel, Dirix, Luc, Machiels, Jean Pascal, Borchiellini, Dephine, Delva, Remy, Rolland, Frederic, Hadaschik, Boris, Retz, Margitta, Rosenbaum, Eli, Basso, Umberto, Mosca, Alessandra, Shin, Dong Bok, Cebotaru, Cristina, Duran, Ignacio, Moreno, Victor, Perez Gracia, Jose Luis, Pinto, Alvaro, Su, Wen-Pin, Wang, Shian-Shiang, Schnadig, Ian, Srinivas, Sandhya, Vogelzang, Nicholas, Loidl, Wolfgang, Meran, Johannes, Gross Goupil, Marine, Joly, Florence, Imkamp, Florian, Krege, Susanne, May, Matthias, Schultze-Seemann, Wolfgang, Strauss, Arne, Zimmermann, Uwe, Keizman, Daniel, Peer, Avivit, Sella, Avishai, Berardi, Rossana, De Giorgi, Ugo, Sternberg, Cora Nanette, Rha, Sun Young, Bulat, Iurie, Izmailov, Adel, Matveev, Vsevolod, Vladimirov, Vladimir, Carles, Joan, Font, Albert, Saez, Maribel, Syndikus, Isabel, Tarver, Kathryn, Appleman, Leonard, Burke, John, Dawson, Nancy, Jain, Sharad, Zakharia, Yousef

Volltext

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Ur... von Crabb, Simon J, Hussain, Syed, Soulis, Eileen, Hinsley, Samantha, Dempsey, Laura, Trevethan, Avril, Song, YeePei, Barber, Jim, Frew, John, Gale, Joanna, Faust, Guy, Brock, Susannah, McGovern, Ursula, Parikh, Omi, Enting, Deborah, Sundar, Santhanam, Ratnayake, Gihan, Lees, Kathryn, Birtle, Alison J, Powles, Thomas, Jones, Robert J

Volltext

Tivozanib (T) as first-line (1L) treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in North-West of England (NWE), UK von Heseltine, Jonathan, Allison, Jennifer, Wong, Sam, Prasad, Kellati, Wong, Helen, Oong, Zhu, Charnley, Natalie, Law, Andrea, Parikh, Omi, Pillai, Manon Rhys, Waddell, Tom, Griffiths, Richard, Chow, Shien

Volltext

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial von Parker, Chris C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Ali, Adnan, Amos, Claire L, Attard, Gerhardt, Chowdhury, Simon, Cook, Adrian, Cross, William, Dearnaley, David P, Douis, Hassan, Gilbert, Duncan C, Gilson, Clare, Gillessen, Silke, Hoyle, Alex, Jones, Rob J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Rauchenberger, Mary, Rush, Hannah, Russell, J Martin, Sweeney, Hannah, Bahl, Amit, Birtle, Alison, Capaldi, Lisa, Din, Omar, Ford, Daniel, Gale, Joanna, Henry, Ann, Hoskin, Peter, Kagzi, Mohammed, Lydon, Anna, O'Sullivan, Joe M, Paisey, Sangeeta A, Parikh, Omi, Pudney, Delia, Ramani, Vijay, Robson, Peter, Srihari, Narayanan Nair, Tanguay, Jacob, Parmar, Mahesh K B, Sydes, Matthew R

Volltext

Real world prospective evaluation of clinical outcomes in patients with non-metastatic castrate resistant prostate cancer treated with darolutamide von Challapalli, Amarnath, Renninson, Emily, White, Paul, Elumalai, Thiraviyam, Parikh, Omi, Vickers, Alexander, Birtle, Alison Jane, Brocklehurst, Andrew, Bhana, Rajanee, Wickramasinghe, Kanchana, Jayaprakash, Kamalram Thippu, Gray, Emma, Sephton, Matthew, Bowzyk Al-Naeeb, Anna, Foulstone, Emily, Soundy, Alexandra, Ashurst, Lauren, Bahl, Amit

Volltext